XML 49 R38.htm IDEA: XBRL DOCUMENT

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2016

Segment Reporting [Abstract]

Summary Of Segment Performance



		For the Three Months Ended September 30,
			CAG		Water			LPD			Other			Unallocated Amounts			Consolidated Total
2016
Revenue		$	385,288		$	27,862		$	29,799		$	5,359		$	-		$	448,308

Income (loss) from operations		$	77,493		$	12,442		$	3,026		$	1,008		$	(5,510)		$	88,459
Interest expense, net																		(6,935)
Income before provision for income taxes																		81,524
Provision for income taxes																		25,072
Net income																		56,452
Less: Net loss attributable to noncontrolling interest																		(3)
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	56,455

2015
Revenue		$	344,081		$	25,957		$	30,448		$	5,901		$	-		$	406,387

Income (loss) from operations		$	61,483		$	12,642		$	6,061		$	569		$	(8,860)		$	71,895
Interest expense, net																		(7,066)
Income before provision for income taxes																		64,829
Provision for income taxes																		20,600
Net income																		44,229
Less: Net income attributable to noncontrolling interest																		6
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	44,223


		For the Nine Months Ended September 30,
			CAG		Water			LPD			Other			Unallocated Amounts			Consolidated Total
2016
Revenue		$	1,143,150		$	79,243		$	93,511		$	16,523		$	-		$	1,332,427

Income (loss) from operations		$	229,858		$	34,864		$	12,665		$	(749)		$	(10,224)		$	266,414
Interest expense, net																		(21,695)
Income before provision for income taxes																		244,719
Provision for income taxes																		75,036
Net income																		169,683
Less: Net income attributable to noncontrolling interest																		7
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	169,676

2015
Revenue		$	1,020,232		$	72,706		$	93,777		$	15,492		$	-		$	1,202,207

Income (loss) from operations		$	183,086		$	33,954		$	19,596		$	(686)		$	(2,949)		$	233,001
Interest expense, net																		(19,645)
Income before provision for income taxes																		213,356
Provision for income taxes																		65,611
Net income																		147,745
Less: Net income attributable to noncontrolling interest																		16
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	147,729

Summary Of Revenue By Product And Service Category


		For the Three Months Ended						For the Nine Months Ended
		September 30,						September 30,
			2016			2015			2016			2015
CAG segment revenue:
CAG Diagnostics recurring revenue:		$	324,233		$	290,502		$	968,041		$	869,413
IDEXX VetLab® consumables			113,963			98,957			336,483			298,093
IDEXX VetLab service and accessories			14,878			13,675			43,461			41,223
Rapid assay products			48,720			47,534			147,583			143,353
Reference laboratory diagnostic and consulting services			146,672			130,336			440,514			386,744
CAG Diagnostics capital - instruments			31,625			25,989			87,119			70,166
Veterinary software, services and diagnostic imaging systems (1)			29,430			27,590			87,990			80,653
CAG segment revenue			385,288			344,081			1,143,150			1,020,232

Water segment revenue			27,862			25,957			79,243			72,706
LPD segment revenue			29,799			30,448			93,511			93,777
Other segment revenue			5,359			5,901			16,523			15,492
Total revenue		$	448,308		$	406,387		$	1,332,427		$	1,202,207
(1) During the second quarter of 2016, we renamed our customer information management and diagnostic imaging systems product and service category in the CAG segment to veterinary software, services and diagnostic imaging systems. Financial results were not adjusted as a result of this name change.